These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3944684)

  • 41. C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects.
    Gregersen N; Wintzensen H; Christensen SK; Christensen MF; Brandt NJ; Rasmussen K
    Pediatr Res; 1982 Oct; 16(10):861-8. PubMed ID: 7145508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fatty acid oxidation defects as causes of unexpected death in infancy.
    Bennett MJ; Allison F; Pollitt RJ; Variend S
    Prog Clin Biol Res; 1990; 321():349-64. PubMed ID: 2326299
    [No Abstract]   [Full Text] [Related]  

  • 43. [Significance of carnitine analysis in clinical tests].
    Kuwajima M; Kono N; Tarui S
    Nihon Rinsho; 1989 Dec; 48 Suppl():393-6. PubMed ID: 2621909
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical and biochemical presentations in 20 cases of hydroxydicarboxylic aciduria.
    Pollitt RJ
    Prog Clin Biol Res; 1990; 321():495-502. PubMed ID: 2326308
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical protocols concerned with disorders of fatty acid beta oxidation].
    Kania M
    Przegl Lek; 1994; 51(1):25-8. PubMed ID: 8208992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defects in mitochondrial fatty acid oxidation: clinical presentations and their role in sudden infant death.
    Pollitt RJ
    Padiatr Padol; 1993; 28(1):13-7. PubMed ID: 8446423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Metabolic crisis in an infant--is the problem in the mitochondria?].
    Tyni T; Pihko H
    Duodecim; 2002; 118(13):1331-9. PubMed ID: 12239878
    [No Abstract]   [Full Text] [Related]  

  • 48. Defects of metabolism of fatty acids in the sudden infant death syndrome.
    Howat AJ; Bennett MJ; Variend S; Shaw L; Engel PC
    Br Med J (Clin Res Ed); 1985 Jun; 290(6484):1771-3. PubMed ID: 3924247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and biochemical variation and family studies in the multiple acyl-CoA dehydrogenation disorders.
    Rhead WJ; Wolff JA; Lipson M; Falace P; Desai N; Fritchman K; Moon A; Sweetman L
    Pediatr Res; 1987 Apr; 21(4):371-6. PubMed ID: 3574988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The fate of orally ingested 3-phenylpropionic acid.
    Duran M; van Vossen R; Bruinvis L; Ketting D; Dorland L; de Klerk JB
    Prog Clin Biol Res; 1990; 321():419-26. PubMed ID: 2326303
    [No Abstract]   [Full Text] [Related]  

  • 51. The diagnosis and biochemical investigation of a patient with a short chain fatty acid oxidation defect.
    Bennett MJ; Gray RG; Isherwood DM; Murphy N; Pollitt RJ
    J Inherit Metab Dis; 1985; 8 Suppl 2():135-6. PubMed ID: 3930866
    [No Abstract]   [Full Text] [Related]  

  • 52. Green enzymes and suicide substrates: a look at the acyl-CoA dehydrogenases in fatty acid oxidation.
    Thorpe C
    Trends Biochem Sci; 1989 Apr; 14(4):148-51. PubMed ID: 2658223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reye syndrome: rate of oxidation of fatty acids in leukocytes and serum levels of lipid peroxides.
    Yoshida Y; Singh I; Singh AK; Tecklenberg FW; Brown FR; Darby CP
    J Exp Pathol; 1989; 4(3):133-9. PubMed ID: 2769452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between unusual hepatic acyl coenzyme A profiles and the pathogenesis of Reye syndrome.
    Corkey BE; Hale DE; Glennon MC; Kelley RI; Coates PM; Kilpatrick L; Stanley CA
    J Clin Invest; 1988 Sep; 82(3):782-8. PubMed ID: 3417871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dicarboxylic aciduria, significance and prognostic indications.
    Treacy E; Pitt J; Eggington M; Hawkins R
    Eur J Pediatr; 1994 Dec; 153(12):918. PubMed ID: 7859795
    [No Abstract]   [Full Text] [Related]  

  • 56. Inhibition of mitochondrial fatty acid oxidation in pentenoic acid-induced fatty liver. A possible model for Reye's syndrome.
    Thayer WS
    Biochem Pharmacol; 1984 Apr; 33(8):1187-94. PubMed ID: 6712730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Mitochondrial beta-oxidation defects: overview].
    Yamaguchi S
    Ryoikibetsu Shokogun Shirizu; 2001; (36):60-4. PubMed ID: 11596451
    [No Abstract]   [Full Text] [Related]  

  • 58. Deficiency in short-chain fatty acid beta-oxidation affects theta oscillations during sleep.
    Tafti M; Petit B; Chollet D; Neidhart E; de Bilbao F; Kiss JZ; Wood PA; Franken P
    Nat Genet; 2003 Jul; 34(3):320-5. PubMed ID: 12796782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperuricemia in medium-chain acyl-coenzyme A dehydrogenase deficiency.
    Davidson-Mundt A; Luder AS; Greene CL
    J Pediatr; 1992 Mar; 120(3):444-6. PubMed ID: 1538296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Reye syndrome and Reye-like syndrome].
    Kimura A
    Nihon Rinsho; 2011 Mar; 69(3):455-9. PubMed ID: 21400838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.